Liver Transplants Reach Record Highs in the U.S. What’s Driving Growth? - Report - MDSpire
Advertisement
Liver Transplants Reach Record Highs in the U.S. What’s Driving Growth?
The number of liver transplants performed in the United States is higher than it’s ever been. For patients in need, including those with end-stage liver disease, acute liver failure or liver cancer, it’s life-saving news.
Record High Liver Transplants in the U.S.: Key Drivers of Growth
Overview
Liver transplants in the U.S. have reached unprecedented numbers, with 12,344 performed in 2025. Advances in organ preservation technology, improved patient screening, and streamlined transfer processes are major contributors to this growth.
Background
Liver transplantation is a critical treatment for patients with end-stage liver disease, acute liver failure, or liver cancer. Historically, the number of liver transplants in the U.S. was in the mid-6,000s annually, but recent years have seen a steady increase. This growth is driven by technological innovations and evolving clinical practices that enhance organ viability and patient selection. The USC Transplant Institute, a leader in transplantation, highlights these advances as pivotal to expanding transplant capacity.
Data Highlights
Year
Number of Liver Transplants
2023
10,660
2024
11,458
2025
12,344
Key Findings
Machine perfusion technology has significantly increased viable donor organ supply by preserving organs longer and allowing real-time viability assessment.
Normothermic regional perfusion (NRP) offers a cost-effective method with potential for improved graft survival and is gaining adoption in the U.S.
Enhanced screening protocols for alcohol-related liver disease improve transplant candidate selection and post-transplant outcomes.
Efficient patient transfer systems and multidisciplinary communication at transplant centers expedite timely transplantation.
The opioid epidemic has indirectly contributed to increased organ availability due to deaths from anoxic brain injuries.
Experimental approaches like xenotransplantation are emerging but not yet widely available.
Clinical Implications
Clinicians should consider early referral to transplant centers to optimize patient outcomes, especially given improved screening and transfer protocols. Adoption of machine perfusion technologies can expand donor organ utilization and improve graft survival. Awareness of evolving practices in alcohol-related liver disease management is essential for transplant candidacy evaluation.
Conclusion
The record growth in liver transplants reflects cumulative advances in technology, patient management, and organ availability. Continued innovation and collaboration among transplant teams promise sustained improvements in liver transplant outcomes.
References
Sturdevant ML, USC Transplant Institute, 2025 -- Liver Transplants Reach Record Highs in the U.S. What’s Driving Growth?